Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
1
-
21por Akan, Aysegul, Civelek, Ersoy, Erkocoglu, Mustafa, Ozcan, Celal, Azkur, Dilek, Toyran, Muge, Gokce, Yasemin, Ozdemir, Tali, Guler, Sedat, Kocabas, Can NaciEnlace del recurso
Publicado 2011
Enlace del recurso
Online Artículo Texto -
22
-
23“…Our preclinical data demonstrate that an intravenous injection of Modified Vaccinia virus Ankara induces CD8(+) lymphocytes to infiltrate organs to control the growth of orthotopic renal carcinoma upon combination with a toll-like receptor 9 agonist. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
24por Büyüktiryaki, Mehmet, Canpolat, Fuat Emre, Alyamaç Dizdar, Evrim, Okur, Nilüfer, Kadıoğlu Şimşek, Gülsüm“…We retrospectively reviewed the medical records of all Syrian immigrants from the TurkishSyrian border who delivered the Zekai Tahir Burak Maternity and Teaching Hospital Neonatal Intensive Care Unit (NICU) in Ankara, Turkey. Between January 2013 and December 2014 a total of 36,346 women gave birth at this center. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
25por Okeke, Malachy I., Okoli, Arinze S., Diaz, Diana, Offor, Collins, Oludotun, Taiwo G., Tryland, Morten, Bøhn, Thomas, Moens, Ugo“…Modified vaccinia virus Ankara (MVA) is the vector of choice for human and veterinary applications due to its strong safety profile and immunogenicity in vivo. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
26“…This study aimed to evaluate the outcomes of pregnancies with increased NT at Başkent University Ankara Hospital between 2004 and 2016. MATERIALS AND METHODS: Patients with NT measurements ≥1.5 multiples of median (MoM) were divided into two groups; group I included increased NT cases without fetal anomalies (either abnormal fetal karyotype or congenital structural anomalies) or loss (intrauterine fetal death), and group II included increased NT cases with fetal anomalies or loss. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
27por Sutter, GerdEnlace del recurso
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
28“…In this communication, we evaluated the efficacy and safety of two SARS vaccine candidates based on the recombinant modified vaccinia Ankara (MVA) expressing SARS-CoV spike or nucleocapsid proteins in ferrets. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
29por Jordan, Ingo, Horn, Deborah, Oehmke, Stefanie, Leendertz, Fabian H., Sandig, Volker“…Surprisingly, the cell lines are fully permissive for a highly attenuated poxvirus, modified vaccinia Ankara (MVA). MVA is a safe and well characterized vaccine vector that cannot replicate in most mammalian cells. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
30
-
31por Hussein, Diala, D’Alessandro, Hilal Dinçer, Batuk, Merve Özbal, Ekhwan, Amar, Sennaroğlu, Gonca“…METHODS: The “Maternal Views on Infant Hearing Loss” questionnaire was adapted and translated into Arabic and then administered to 100 Syrian mothers living in different neighborhoods in Ankara within the age range of 18–68 years old. The internal consistency for the main domains of the questionnaire was tested by Cronbach’s alpha coefficient. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
32
-
33por Lauterbach, Henning, Kassub, Ronny, Pätzold, Juliane, Körner, Jana, Brückel, Michael, Verschoor, Admar, Chaplin, Paul, Suter, Mark, Hochrein, Hubertus“…Using the mousepox model, we investigated the immunological mechanisms responsible for a successful post-exposure immunization with modified vaccinia Ankara (MVA). In contrast to intranasal application of MVA, we found that intravenous immunization fully protected mice infected with ectromelia virus (ECTV) when applied three days after infection. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
34por Bohnen, C, Wangorsch, A, Schülke, S, Burggraf, M, Suezer, Y, Schwantes, A, Sutter, G, Waibler, Z, Reese, G, Toda, M, Scheurer, S, Vieths, SEnlace del recurso
Publicado 2013
Enlace del recurso
Online Artículo Texto -
35
-
36por VAZIRI, Yashar, BULDUK, Sidika, SHADMAN, Zhaleh, BULDUK, Emre Ozgur, HEDAYATI, Mehdi, KOC, Haluk, ER, Fatmanur, ERDOGAN, Ceren Suveren“…BACKGROUND: The aim of this study was to assess the predictive capacity of body composition estimated by bioelectrical impedance analysis (BIA) to identify abnormal blood pressure in physical education and sport teaching students in the city of Ankara. METHODS: Data for this cross-sectional study were obtained in the city of Ankara in 2014. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
37por Büyüktiryaki, Mehmet, Canpolat, Fuat Emre, Dizdar, Evrim Alyamaç, Okur, Nilüfer, Şimşek, Gülsüm KadıoğluEnlace del recurso
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
38“…We found that standard vaccine preparations of recombinant Modified Vaccinia virus Ankara produce only about 20–30% plaque-forming virions in fully permissive cell cultures. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
39por Hebben, Matthias, Duquesne, Véronique, Cronier, Joëlle, Rossi, Bernard, Aubert, André“…In our study, we report the construction of another poxvirus, the modified vaccinia virus Ankara (MVA), as an expression vector for the FIPV M protein. …”
Publicado 2004
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
40“…METHODS: The study was carried out on 418 healthcare professionals working in a training and research hospital in Ankara/Turkey. The survey method was used as data collection tool. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto